Marshall Wace, LLP Meira G Tx Holdings PLC Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$6.8 - $14.23 $221,510 - $463,542	32,575 New	32,575 $249,000
Q3 2020 Nov 16, 2020	SELL	$11.59 - $14.93 $341,719 - $440,196	-29,484 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$11.79 - $15.97 $77,342 - $104,763	-6,560 Reduced 18.2%	29,484 $369,000
Q1 2020 May 15, 2020	BUY	$9.31 - $21.24 $210,070 - $479,259	22,564 Added 167.39%	36,044 $484,000
Q4 2019 Feb 14, 2020	BUY	$13.91 - $21.48 $155,472 - $240,081	11,177 Added 485.32%	13,480 $270,000
Q3 2019 Nov 14, 2019	BUY	$15.84 - $30.01 $36,479 - $69,113	2,303 New	2,303 $37,000

102

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $282M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.